Freenome
Developer of a multi-omics platform designed to detect cancer through a routine blood draw.
Decision/Risk Analysis
📍 Brisbane, CA
Founded 2014
Current Valuation
$2.2B
as of 2024-Q1
UNICORN
Developer of a multi-omics platform designed to detect cancer through a routine blood draw.
Company Profile
Last Round
Later Stage VC — $254M (Feb 2024)
Fundraising Status
Later Stage VC · $254M · 2y 4mo ago
privateTotal raised $1.4B
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Later Stage VC | $254M | Feb 2024 | — | $2.2B |
Health CareBiotechnologyPersonal HealthHealth Diagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q1. Refreshed quarterly.